Medline Inc. (MDLN) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 25, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Medline Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Medline Inc.'s filing signal continuing positive.
earningsVibe SuperAnalyst™ Verdict: CONTINUING POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-14.16%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Positive
GEMINI
Continuing Positive
CLAUDE
Continuing Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Medline Inc. actually do?
Answer:
Medline Inc. is the largest provider of medical-surgical products and supply chain solutions, serving all points of care across the healthcare continuum. Founded in 1966, the company offers a comprehensive range of approximately 335,000 med-surg products through its two reportable segments: Medline Brand and Supply Chain Solutions. Medline Brand focuses on proprietary products across categories like Front Line Care and Surgical Solutions, while Supply Chain Solutions distributes third-party national brands and offers optimization services. The company operates an extensive distribution network of 70 global facilities, supported by its own fleet of over 2,100 trucks, and utilizes AI and robotics in its warehouses. Medline's business model is anchored by its Prime Vendor relationships, which are multi-year distribution agreements that consolidate a customer's med-surg product needs with Medline as the primary partner, driving significant cost savings and customer retention.
Question:
What are Medline Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by the sale of medical-surgical products, both its own Medline Brand products and those from third-party suppliers. A significant portion of revenue is generated through its Prime Vendor model, where customers commit to sourcing the majority of their med-surg product needs from Medline.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required